Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920318 · ClinicalTrials.gov registry record · NA
Enhancing Language Function in Primary Progressive Aphasia
A NA study of Primary Progressive Aphasia, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04920318: Recruiting NA study of Primary Progressive Aphasia, sponsored by University of Arizona.
NCT04920318 is a NA study of Primary Progressive Aphasia that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 20 participants, below the 91-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04920318, a NA study of Primary Progressive Aphasia, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's goal is to use non-invasive brain stimulation (NBS) techniques to treat language impairment associated with Primary Progressive Aphasia (PPA). The purpose of this study is to combine behavioral language intervention with individualized noninvasive brain stimulation techniques, called transcranial direct current stimulation (tDCS) to help the brain reorganize around damage and improve language functions.
Primary Outcome
Mean change from baseline scores on the Arizona Phonological Battery: Minimum score = 0; maximum = 100%; higher scores indicate better outcome
Conditions Studied
Interventions
- COMBINATION_PRODUCT tDCS + language therapy
- COMBINATION_PRODUCT sham TDCS + language therapy
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2027-06-15 |
| Phase | NA |
What NCT04920318 shows while recruiting
NCT04920318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 91-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Primary Progressive Aphasia appearing as the primary indexed condition, and to 2 interventions - of which tDCS + language therapy is the first listed.
NCT04920318 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT04920318 about?
NCT04920318 is a clinical study titled "Enhancing Language Function in Primary Progressive Aphasia". This study's goal is to use non-invasive brain stimulation (NBS) techniques to treat language impairment associated with Primary Progressive Aphasia (PPA). The purpose of this study is to combine behavioral language intervention with individualized noninvasive brain stimulation techniques, called tr...
What is the current status of trial NCT04920318?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-08-30. Estimated completion is 2027-06-15.
What conditions does trial NCT04920318 study?
This clinical trial studies the following conditions: Primary Progressive Aphasia.
What interventions are being tested in trial NCT04920318?
The interventions under investigation include: tDCS + language therapy (COMBINATION_PRODUCT), sham TDCS + language therapy (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04920318?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04920318 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Progressive Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04920318's enrollment target sits among peer trials
20 12th of 15 higher than 4 of 15 other Primary Progressive Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Primary Progressive Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Language Function in Aphasia
RECRUITING · NA
-
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
RECRUITING · NA
-
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
RECRUITING · NA
-
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
ACTIVE NOT RECRUITING · NA
-
Treatment for Speech and Language in Primary Progressive Aphasia
ACTIVE NOT RECRUITING · NA
-
Communication Bridge Pilot Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI